Association of metabolic risk factors with cartilage degradation assessed by t2 relaxation time at the knee: Data from the osteoarthritis initiative

Arthritis Care and Research

Volumn 65, Issue 12, 2013, Pages 1942-1950

  Jungmann, P M ^a,b   Kraus, M S ^a   Alizai, H ^a,c   Nardo, L ^a   Baum, T ^a,b   Nevitt, M C ^a   McCulloch, C E ^a   Joseph, G B ^a   Lynch, J A ^a   Link, T M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CARTILAGE DEGENERATION; COHORT ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; FAT INTAKE; HUMAN; HYPERTENSION; KNEE FUNCTION; KNEE OSTEOARTHRITIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OBSERVATIONAL STUDY; RELAXATION TIME; RISK FACTOR; SELF REPORT; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

CARTILAGE, ARTICULAR; DIABETES MELLITUS; DIET; DIETARY FATS; FEMALE; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOARTHRITIS, KNEE; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84889068084     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22093     Document Type: Article

References (56)

1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al, for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum 2008; 58: 26-35.
2. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000; 133: 635-46.
3. Reijman M, Pols HA, Bergink AP, Hazes JM, Belo JN, Lievense AM, et al. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam study. Ann Rheum Dis 2007; 66: 158-62.
4. Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM,. Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 1995; 38: 1134-41.
5. Burstein D, Gray M,. New MRI techniques for imaging cartilage. J Bone Joint Surg Am 2003; 85-A Suppl: 70-7.
6. Burstein D, Gray M, Mosher T, Dardzinski B,. Measures of molecular composition and structure in osteoarthritis. Radiol Clin North Am 2009; 47: 675-86.
7. Link TM, Steinbach LS, Ghosh S, Ries M, Lu Y, Lane N, et al. Osteoarthritis: MR imaging findings in different stages of disease and correlation with clinical findings. Radiology 2003; 226: 373-81.
8. Ding C, Cicuttini F, Scott F, Cooley H, Jones G,. Knee structural alteration and BMI: a cross-sectional study. Obes Res 2005; 13: 350-61.
9. Dunn TC, Lu Y, Jin H, Ries MD, Majumdar S,. T2 relaxation time of cartilage at MR imaging: comparison with severity of knee osteoarthritis. Radiology 2004; 232: 592-8.
10. Eckstein F, Cicuttini F, Raynauld JP, Waterton JC, Peterfy C,. Magnetic resonance imaging (MRI) of articular cartilage in knee osteoarthritis (OA): morphological assessment. Osteoarthritis Cartilage 2006; 14 Suppl: A46-75.
11. Joseph GB, Baum T, Alizai H, Carballido-Gamio J, Nardo L, Virayavanich W, et al. Baseline mean and heterogeneity of MR cartilage T2 are associated with morphologic degeneration of cartilage, meniscus, and bone marrow over 3 years: data from the Osteoarthritis Initiative. Osteoarthritis Cartilage 2012; 20: 727-35.
12. Baum T, Stehling C, Joseph GB, Carballido-Gamio J, Schwaiger BJ, Muller-Hocker C, et al. Changes in knee cartilage T2 values over 24 months in subjects with and without risk factors for knee osteoarthritis and their association with focal knee lesions at baseline: data from the Osteoarthritis Initiative. J Magn Reson Imaging 2012; 35: 370-8.
13. Hovis KK, Stehling C, Souza RB, Haughom BD, Baum T, Nevitt M, et al. Physical activity is associated with magnetic resonance imaging-based knee cartilage T2 measurements in asymptomatic subjects with and without osteoarthritis risk factors. Arthritis Rheum 2011; 63: 2248-56.
14. Pan J, Pialat JB, Joseph T, Kuo D, Joseph GB, Nevitt MC, et al. Knee cartilage T2 characteristics and evolution in relation to morphologic abnormalities detected at 3-T MR imaging: a longitudinal study of the normal control cohort from the Osteoarthritis Initiative. Radiology 2011; 261: 507-15.
15. Prasad AP, Nardo L, Schooler J, Joseph GB, Link TM,. T(1)ρ and T(2) relaxation times predict progression of knee osteoarthritis. Osteoarthritis Cartilage 2013; 21: 69-76.
16. Katz JD, Agrawal S, Velasquez M,. Getting to the heart of the matter: osteoarthritis takes its place as part of the metabolic syndrome. Curr Opin Rheumatol 2010; 22: 512-9.
17. Sowers M, Karvonen-Gutierrez CA, Palmieri-Smith R, Jacobson JA, Jiang Y, Ashton-Miller JA,. Knee osteoarthritis in obese women with cardiometabolic clustering. Arthritis Rheum 2009; 61: 1328-36.
18. Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T,. Association of knee osteoarthritis with the accumulation of metabolic risk factors such as overweight, hypertension, dyslipidemia, and impaired glucose tolerance in Japanese men and women: the ROAD study. J Rheumatol 2011; 38: 921-30.
19. Zhuo Q, Yang W, Chen J, Wang Y,. Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol 2012; 8: 729-37.
20. Engstrom G, Gerhardsson de Verdier M, Rollof J, Nilsson PM, Lohmander LS,. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis: a population-based cohort study. Osteoarthritis Cartilage 2009; 17: 168-73.
21. Puenpatom RA, Victor TW,. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med 2009; 121: 9-20.
22. Peterfy CG, Schneider E, Nevitt M,. The Osteoarthritis Initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee. Osteoarthritis Cartilage 2008; 16: 1433-41.
23. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW,. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 1833-40.
24. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-5.
25. Alberti KG, Zimmet P, Shaw J,. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366: 1059-62.
26. Freiberg MS, Cabral HJ, Heeren TC, Vasan RS, Curtis Ellison R,. Alcohol consumption and the prevalence of the metabolic syndrome in the US: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2954-9.
27. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460-8.
28. Van Dijk SJ, Feskens EJ, Bos MB, de Groot LC, de Vries JH, Muller M, et al. Consumption of a high monounsaturated fat diet reduces oxidative phosphorylation gene expression in peripheral blood mononuclear cells of abdominally overweight men and women. J Nutr 2012; 142: 1219-25.
29. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995; 854: 1-452.
30. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: 1-253.
31. Freire RD, Cardoso MA, Gimeno SG, Ferreira SR,. Dietary fat is associated with metabolic syndrome in Japanese Brazilians. Diabetes Care 2005; 28: 1779-85.
32. Lottenberg AM, Afonso Mda S, Lavrador MS, Machado RM, Nakandakare ER,. The role of dietary fatty acids in the pathology of metabolic syndrome. J Nutr Biochem 2012; 23: 1027-40.
33. Wang Y, Davies-Tuck ML, Wluka AE, Forbes A, English DR, Giles GG, et al. Dietary fatty acid intake affects the risk of developing bone marrow lesions in healthy middle-aged adults without clinical knee osteoarthritis: a prospective cohort study. Arthritis Res Ther 2009; 11: R63.
34. Sharma S, Murphy SP, Wilkens LR, Shen L, Hankin JH, Henderson B, et al. Adherence to the Food Guide Pyramid recommendations among Japanese Americans, Native Hawaiians, and whites: results from the Multiethnic Cohort Study. J Am Diet Assoc 2003; 103: 1195-8.
35. Carballido-Gamio J, Joseph GB, Lynch JA, Link TM, Majumdar S,. Longitudinal analysis of MRI T2 knee cartilage laminar organization in a subset of patients from the Osteoarthritis Initiative: a texture approach. Magn Reson Med 2011; 65: 1184-94.
36. Souza RB, Stehling C, Wyman BT, Hellio Le Graverand MP, Li X, Link TM, et al. The effects of acute loading on T1ρ and T2 relaxation times of tibiofemoral articular cartilage. Osteoarthritis Cartilage 2010; 18: 1557-63.
37. Stehling C, Baum T, Mueller-Hoecker C, Liebl H, Carballido-Gamio J, Joseph GB, et al. A novel fast knee cartilage segmentation technique for T(2) measurements at MR imaging: data from the Osteoarthritis Initiative. Osteoarthritis Cartilage 2011; 19: 984-9.
38. Pan J, Stehling C, Muller-Hocker C, Schwaiger BJ, Lynch J, McCulloch CE, et al. Vastus lateralis/vastus medialis cross-sectional area ratio impacts presence and degree of knee joint abnormalities and cartilage T2 determined with 3T MRI: an analysis from the incidence cohort of the Osteoarthritis Initiative. Osteoarthritis Cartilage 2011; 19: 65-73.
39. Berger MJ, Kean CO, Goela A, Doherty TJ,. Disease severity and knee extensor force in knee osteoarthritis: data from the Osteoarthritis Initiative. Arthritis Care Res (Hoboken) 2012; 64: 729-34.
40. Baum T, Joseph GB, Arulanandan A, Nardo L, Virayavanich W, Carballido-Gamio J, et al. Association of magnetic resonance imaging-based knee cartilage T2 measurements and focal knee lesions with knee pain: data from the Osteoarthritis Initiative. Arthritis Care Res (Hoboken) 2012; 64: 248-55.
41. Baum T, Joseph GB, Nardo L, Virayavanich W, Arulanandan A, Alizai H, et al. Correlation of magnetic resonance imaging-based knee cartilage T2 measurements and focal knee lesions with body mass index: thirty-six-month followup data from a longitudinal, observational multicenter study. Arthritis Care Res (Hoboken) 2013; 65: 23-33.
42. Li X, Pai A, Blumenkrantz G, Carballido-Gamio J, Link T, Ma B, et al. Spatial distribution and relationship of T1ρ and T2 relaxation times in knee cartilage with osteoarthritis. Magn Reson Med 2009; 61: 1310-8.
43. Mosher TJ, Dardzinski BJ,. Cartilage MRI T2 relaxation time mapping: overview and applications. Semin Musculoskelet Radiol 2004; 8: 355-68.
44. Jungmann P, Kraus M, Nardo L, Liebl H, Alizai G, Joseph G, et al. T2 relaxation time measurements are limited in monitoring progression, once advanced cartilage defects at the knee occur: longitudinal data from the Osteoarthritis Initiative. J Magn Reson Imaging. In press.
45. Crema MD, Roemer FW, Marra MD, Burstein D, Gold GE, Eckstein F, et al. Articular cartilage in the knee: current MR imaging techniques and applications in clinical practice and research. Radiographics 2011; 31: 37-61.
46. Koff MF, Amrami KK, Kaufman KR,. Clinical evaluation of T2 values of patellar cartilage in patients with osteoarthritis. Osteoarthritis Cartilage 2007; 15: 198-204.
47. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
48. Carman WJ, Sowers M, Hawthorne VM, Weissfeld LA,. Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study. Am J Epidemiol 1994; 139: 119-29.
49. Ghroubi S, Elleuch H, Guermazi M, Kaffel N, Feki H, Abid M, et al. Abdominal obesity and knee osteoarthritis. Ann Readapt Med Phys 2007; 50: 661-6. In French.
50. Laakso M,. Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes. Prim Care 1999; 26: 829-39.
51. Mattila TK, de Boer A,. Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus. Drugs 2010; 70: 2229-45.
52. Hart DJ, Doyle DV, Spector TD,. Association between metabolic factors and knee osteoarthritis in women: the Chingford study. J Rheumatol 1995; 22: 1118-23.
53. Davis MA, Ettinger WH, Neuhaus JM,. The role of metabolic factors and blood pressure in the association of obesity with osteoarthritis of the knee. J Rheumatol 1988; 15: 1827-32.
54. Hynes GR, Jones PJ,. Leptin and its role in lipid metabolism. Curr Opin Lipidol 2001; 12: 321-7.
55. Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004; 292: 1433-9.
56. Salto LM, Cordero-MacIntyre Z, Beeson L, Schulz E, Firek A, De Leon M,. En Balance participants decrease dietary fat and cholesterol intake as part of a culturally sensitive Hispanic diabetes education program. Diabetes Educ 2011; 37: 239-53.